Should I Give Anti-Edema in This TBI?

Good posts start with good questions. Have an ER question? Send it here.

KEY

🔍- Deep Dive

📌- Clinical Application

🔸 - Weak Evidence

🔹 - Strong Evidence

📑 - Evidence summaries

✅ - Recommended treatment

⚠️ - Critical Information

This is in answer to a question I was asked recently and honestly, I had a lot of fun answering it.

Raised intracranial pressure is one of those topics that feels overwhelming at first. There are numbers, formulas, drugs, and guidelines

but once you understand the why, everything starts to fall into place.

Let’s break it down the way we actually think about it in the emergency department.

Before we start we need to understand a few concepts

👉

Jump to what matters ⏬

What is ICP (Intracranial Pressure)?

As the name suggests, the cranial vault is a rigid, non-expandable compartment, containing three things:

Brain (~80%)

Blood

Cerebrospinal fluid (CSF).

Intracranial Pressure (ICP) is simply the pressure within this closed space.

Imagine a closed, rigid cube containing three components—brain, blood, and CSF.

Now imagine all of them pushing against each other within that fixed space. The pressure generated inside this cube is what we call intracranial pressure (ICP).

That sounds straightforward, but this single concept drives everything we do in managing brain-injured patients.

Monro-Kellie Doctrine :

Once we accept that the brain exists within a fixed, closed space, an increase in one component must be compensated by a decrease in another to maintain ICP.

Initially, changes in volume cause relatively little increase in pressure due to

Displacement of CSF into the spinal subarachnoid space

Compression of vascular bed

Displacement of blood from the venous sinuses

Increased CSF reabsorption

But beyond a certain point, these compensations will fail and the pressure will rapidly increase ending up in brain herniation.

As the brain part expands inside the cube, the liquid layers (blood and CSF) get pushed out and start leaking.

When the cube can’t accommodate any more, the inner contents bulge and start forcing their way out of the cube itself.

The clinical significance is that even small increases in intracranial volume can cause a rapid rise in ICP once compensatory mechanisms fail.

🔍

This leads to:

Hypertension → to maintain CPP

Bradycardia → due to baroreceptor response

Irregular respiration → due to brainstem dysfunction

This combination is known as the Cushing reflex, a late, ominous sign of medullary ischemia.

CPP, MAP & ICP Relation

Cerebral perfusion depends on the balance between systemic pressure and intracranial pressure:

CPP=MAP−ICP

CPP (Cerebral Perfusion Pressure) = Blood flow to the brain

If ICP ↑ → CPP ↓ → Brain ischemia

So the entire point of fixing ICP is to ensure that brain gets enough blood supply.

What is “normal” when we talk about ICP and CPP?

In a healthy person, ICP usually sits around 7–15 mmHg.

Once it starts crossing 20–22 mmHg, that’s when we begin to worry and think about treatment.

And what about CPP?

CPP is really what the brain cares about, because that’s what determines blood flow.

Normally, CPP is around 50–90 mmHg

In brain-injured patients, we aim for about 60–70 mmHg (as per ACS guidelines 2024) 1

If CPP drops below 50–60 mmHg, the brain starts getting underperfused.

but there are some caveats here

Someone with longstanding hypertension is used to higher pressures
→ so they may actually need a higher CPP to stay well perfused

And in real life, we don’t always know the ICP

✅

So if you suspect raised ICP but don’t have a number?

It’s reasonable to keep the MAP a bit higher (around 80 mmHg) to protect perfusion.

Now how do we know ICP is raised?

Symptoms & Clinical Features

Headache : Typically worse on lying down, coughing, or anything that increases intracranial pressure further.

Vomiting : Often projectile and not preceded by nausea.

Altered consciousness

Visual disturbances : Blurring, diplopia, or transient visual obscurations.

Abducens nerve palsy

The 6th nerve has a long intracranial course, making it particularly vulnerable to pressure changes

It gets anchored at Dorello’s canal, near the brainstem

When ICP rises, the brain is pushed downward → this causes stretching of the nerve

Result: lateral rectus palsy → diplopia

Cushing’s Triad

Hypertension

Bradycardia

Irregular respirations

⚠️ This is a pre-terminal sign

Using POCUS in Raised ICP

ONSD (optic nerve sheath diameter).

The optic nerve sheath is part of dura matter. This means that when ICP rises and CSF pressure increases, the sheath distends.
ONSD ≥6 mm suggests raised ICP, and a change of ≥0.5 mm on serial measurements is clinically significant (B-ICONIC 2025) 1
ONSD is not a substitute for invasive monitoring (B-ICONIC 2025) 2

Papilledema.

Papilledema may be noted on ultrasonography as a protrusion overlying the optic disc.
Overall, papilledema is less well validated than optic nerve sheath diameter.

Gaillard F, Sharma R, Mahsoub M, et al. Papilloedema. Reference article, Radiopaedia.org (Accessed on 22 Mar 2026) https://doi.org/10.53347/rID-1841

MCA pulsatility index (via transcranial doppler)

Automated pupillometry via the neurological pupil index (NPi)

CT Brain

Look for

effacement of the ventricles, basal cisterns and other CSF spaces

brain herniation

loss of grey-white matter differentiation

⚠️

Normal CT imaging doesn't exclude elevation of intracranial pressure

Are all raised ICP the same?

Simple answer: No.

The type of underlying edema matters, because it directly determines how you treat the patient.

1. Vasogenic Edema

What happens?

There is a breakdown of the blood–brain barrier (BBB) → fluid leaks out of capillaries into the extracellular space.

Seen in:

Tumors (classically with surrounding edema)
Infections (abscess, encephalitis)
Inflammatory/demyelinating conditions
Cerebral venous thrombosis
PRES

How to manage:

Responds to steroids
Osmotherapy may be less effective

🔍

Osmotherapy works by creating a concentration difference (osmotic gradient) that pulls water out of the brain.

But here, the BBB is damaged:

The barrier cannot maintain this gradient

Osmotic agents can leak into brain tissue

So the effect becomes reduced or short-lived

2. Cytotoxic Edema

What happens?

This is cellular injury → neurons swell due to failure of ion pumps → water moves into cells

Seen in:

Ischemic stroke
Hypoxic brain injury
Prolonged seizures

How to manage:

Does NOT respond to steroids
Osmotherapy can help

🔍

Because the problem is failure of ion pumps, not at the blood–brain barrier.

Steroids mainly act by stabilizing the blood–brain barrier and reducing leakage.

This is why studies (like the CRASH trial in TBI) showed no benefit and even harm with steroid use.

3. Interstitial (Hydrostatic) Edema

What happens?

CSF builds up due to hydrocephalus and leaks into surrounding brain tissue.

Seen in:

Obstructive hydrocephalus

How to manage:

Treat the cause by draining CSF

4. Osmotic Edema

What happens?

Water shifts into the brain due to an osmotic imbalance

Seen in:

Acute hyponatremia
Dialysis disequilibrium
Rapid withdrawal of hyperosmolar therapy (rebound)

How to manage:

Correct the osmotic disturbance carefully

We’ll focus mainly on severe TBI, as it is most relevant in the ER and typically involves a combination of different types of edema.

Now that the physiology makes sense, the management becomes much easier, let’s walk through it.

Tiered Treatment

Let’s start with the tiered approach to managing raised ICP in severe TBI.

For the sake of clarity and consistency, we’ll be using the SIBICC framework here. 3

Guidance for using tiered treatments is based on three principles:

No fixed order within a tier → You don’t have to follow a sequence inside a tier. Choose what fits the patient.

You don’t need to “complete” a tier → Not every intervention in a tier must be used before escalating.

You can skip tiers if needed → In a crashing patient, it’s completely reasonable to jump ahead

✅

This is not a checklist. It’s a framework.

Tier Zero

⚠️

These interventions are not dependent on raised ICP, they should be done in all at-risk patients.

Expected Interventions:

ICU admission
Airway protection → intubation & mechanical ventilation
Serial neurological exams + pupillary checks
Head elevation (30–45°)
Analgesia (pain control)
Sedation (to prevent agitation, coughing, ventilator dyssynchrony)
Temperature control → treat fever (>38°C)
Consider seizure prophylaxis (usually up to 1 week)
Maintain CPP ≥60 mmHg
Maintain hemoglobin >7 g/dL
Avoid hyponatremia
Optimize venous drainage:

Head midline
Avoid tight C-collars

Arterial line for continuous BP monitoring
Maintain SpO₂ ≥94%

Recommended Interventions:

Insertion of a central line
End-tidal CO2 monitoring

Tier One

Maintain CPP 60–70 mmHg

Increase analgesia & sedation

Target PaCO₂: 35–38 mmHg

Osmotherapy:

Mannitol (0.25–1 g/kg bolus)
Hypertonic saline (bolus)

CSF drainage if EVD present

Consider placing EVD if needed

Consider short-term seizure prophylaxis

Consider EEG monitoring

Tier Two

Mild hypocapnia (PaCO₂ 32–35 mmHg)

Neuromuscular paralysis (if already adequately sedated and beneficial)

MAP optimization:

Fluids / vasopressors / inotropes
Especially if autoregulation is intact

⚠️

MAP challenge and advanced autoregulation monitoring are often ICU-level decisions

Tier Three

Barbiturate coma (pentobarbital / thiopentone)

Decompressive craniectomy

Mild hypothermia (35–36°C)

What to do between tiers

At every step:

Re-examine the patient

Consider repeat CT imaging

Reassess for surgical lesions

Ensure physiology is optimized:

CPP
Oxygenation
Blood gases

Escalate care / refer if needed

What not to do?

Continuous (non-bolus) mannitol infusion

Scheduled hyperosmolar therapy (e.g., fixed 4–6 hourly dosing)

Lumbar CSF drainage

Furosemide

Routine use of steroids

Aggressive hypothermia (<35°C)

High-dose propofol

Routine hyperventilation (PaCO₂ <30 mmHg)

Over-aggressive CPP targets (>90 mmHg)

Equally important is the ability to identify and treat critical neuroworsening promptly.

Identifying critical neuroworsening

Drop in GCS motor score ≥1 point from previous exam

New pupillary changes:

Reduced reactivity
Asymmetry
Bilateral dilation

New focal motor deficit

Signs of herniation or Cushing’s triad

Managing critical neuroworsening

Start empiric treatment immediately

Hyperventilation

⚠️

Here, the usual lower limit (PaCO₂ 30 mmHg) does NOT apply

Bolus hypertonic therapy

Urgent imaging

Rapid escalation

Move up tiers quickly
Involve neurosurgery early

Now let’s talk the drugs

What drugs to use?

📌

Mannitol

0.25–1 g/kg IV bolus over 5–15 minutes
Can be repeated every 4–6 hours
Target ~<320 mEq/L

Hypertonic Saline (HTS)

3% HTS

250 mL over 10–15 minutes

5% HTS

2.5–5 mL/kg over 5–20 minutes

Target ~155 mEq/L

Hypertonic sodium bicarbonate (~ 6% HTS)

1–2 ampoules IV over ~10 minutes
Useful when other agents are not immediately available

How does osmotherapy actually work?

Osmotherapy reduces ICP through two main mechanisms:

Osmotic Effects : It mainly works by pulling water out of the brain.

It increases the concentration of blood
This creates a gradient → water moves from brain cells into the bloodstream
This reduces brain swelling and lowers ICP

But this effect is temporary→ the brain adapts over time, which can lead to rebound ICP.

Non-osmotic Effects : Increases intravascular volume

Leads to:

Better cardiac output
Higher blood pressure
Improved cerebral perfusion

Hypertonic Saline vs Mannitol

This is the real clinical decision point.

Advantages

Rapid onset
More hemodynamically stable (
Maintains intravascular volume
Easy monitoring
At least as effective as mannitol

Limitations

Requires central access
Risk of:

Hypernatremia
Fluid overload
Hyperchloremic acidosis
Fluid overload
Altered platelet aggregation.

Avoid in chronic hyponatremia (Rapid shifts → risk of seizures)

Advantages

Cheap and widely available
Rapid ICP reduction
May improve cerebral blood flow

Disadvantages

Causes osmotic diuresis → hypovolemia
Can lead to:

Electrolyte disturbances
Rebound ICP
Requires monitoring of serum osmolality (~<320 mOsm)
Storage issues (precipitates in cold environments)

When to avoid Mannitol

Renal dysfunction
Hypovolemia
Active intracranial bleeding
Disrupted BBB (risk of rebound ICP)
Poor IV access
Concurrent nephrotoxic drugs

🔍

Both mannitol and HTS pull fluid out

but

Mannitol also pulls fluid out of the body

HTS keeps it in the circulation

According to the Brain Trauma Foundation (BTF) 2016 guidelines → no strong recommendation can be made for one agent over another. 4

Osmotherapy in EDH

Mannitol should be avoided or used with extreme caution in extradural hematoma (EDH) because it lowers ICP by reducing brain volume, which can have unintended consequences:

Shrinking the brain reduces the tamponade effect exerted by the brain on the bleeding vessel

In EDH, this pressure may be helping limit ongoing arterial bleeding

Loss of this effect can lead to rapid expansion of the hematoma

Since EDH is typically acute and arterial, this worsening can be sudden and catastrophic

This concept is largely theoretical and anecdotal. There are no strong guideline recommendations advising against osmotherapy in EDH

So in practice

If there are signs of raised ICP, initiate osmotherapy. At the same time, prepare for urgent surgical evacuation (definitive treatment).

However do not initiate osmotherapy unless there is a strong indication like raised ICP or herniation

Other therapies

If ICP is not being monitored (like it usually is in ER) → aim for MAP ≥80 mmHg (ACS 2024 guidelines) 1

SBP target

BTF 2016 guidelines 4 → ≥100 mm Hg (Age 50 to 69 years old) or ≥110 mm Hg (15 to 49 or over 70 years old)
ATLS 10th Edition → ≥100 mm Hg (Age >15 years)